201 related articles for article (PubMed ID: 29869821)
1. DEAD box protein DDX1 promotes colorectal tumorigenesis through transcriptional activation of the LGR5 gene.
Tanaka K; Ikeda N; Miyashita K; Nuriya H; Hara T
Cancer Sci; 2018 Aug; 109(8):2479-2489. PubMed ID: 29869821
[TBL] [Abstract][Full Text] [Related]
2. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
3. DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes.
Tanaka K; Okamoto S; Ishikawa Y; Tamura H; Hara T
Oncogene; 2009 May; 28(21):2142-51. PubMed ID: 19398953
[TBL] [Abstract][Full Text] [Related]
4. Role of Lgr5-positive cells in colorectal cancer.
Ding H; Wang C
Tumour Biol; 2015 Sep; 36(9):6759-64. PubMed ID: 25835970
[TBL] [Abstract][Full Text] [Related]
5. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
6. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
7. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells.
Fafilek B; Krausova M; Vojtechova M; Pospichalova V; Tumova L; Sloncova E; Huranova M; Stancikova J; Hlavata A; Svec J; Sedlacek R; Luksan O; Oliverius M; Voska L; Jirsa M; Paces J; Kolar M; Krivjanska M; Klimesova K; Tlaskalova-Hogenova H; Korinek V
Gastroenterology; 2013 Feb; 144(2):381-391. PubMed ID: 23142137
[TBL] [Abstract][Full Text] [Related]
8. Depleting DDX1 sensitizes non-small cell lung cancer cells to chemotherapy by attenuating cancer stem cell traits.
Yang Q; Xu P; Liu Q; Hu F; Xie X; Jiang L; Bi R; Wang L; Ding F; Xiao H
Life Sci; 2023 Jun; 323():121592. PubMed ID: 36934972
[TBL] [Abstract][Full Text] [Related]
9. DDX1 promotes proliferation of the JC virus through transactivation of its promoter.
Sunden Y; Semba S; Suzuki T; Okada Y; Orba Y; Nagashima K; Umemura T; Sawa H
Microbiol Immunol; 2007; 51(3):339-47. PubMed ID: 17380054
[TBL] [Abstract][Full Text] [Related]
10. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
Xu H; Li J; Chen H; Ghishan FK
Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
[TBL] [Abstract][Full Text] [Related]
11. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
[TBL] [Abstract][Full Text] [Related]
12. The DEAD-box RNA helicase DDX1 interacts with RelA and enhances nuclear factor kappaB-mediated transcription.
Ishaq M; Ma L; Wu X; Mu Y; Pan J; Hu J; Hu T; Fu Q; Guo D
J Cell Biochem; 2009 Feb; 106(2):296-305. PubMed ID: 19058135
[TBL] [Abstract][Full Text] [Related]
13. REG4 is a transcriptional target of GATA6 and is essential for colorectal tumorigenesis.
Kawasaki Y; Matsumura K; Miyamoto M; Tsuji S; Okuno M; Suda S; Hiyoshi M; Kitayama J; Akiyama T
Sci Rep; 2015 Sep; 5():14291. PubMed ID: 26387746
[TBL] [Abstract][Full Text] [Related]
14. Leucine-rich repeat-containing G protein-coupled receptor 5 marks different cancer stem cell compartments in human Caco-2 and LoVo colon cancer lines.
Alharbi SA; Ovchinnikov DA; Wolvetang E
World J Gastroenterol; 2021 Apr; 27(15):1578-1594. PubMed ID: 33958845
[TBL] [Abstract][Full Text] [Related]
15. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
[TBL] [Abstract][Full Text] [Related]
17. GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism.
Zhang S; Chatterjee T; Godoy C; Wu L; Liu QJ; Carmon KS
Mol Cancer Res; 2019 Nov; 17(11):2196-2207. PubMed ID: 31444231
[TBL] [Abstract][Full Text] [Related]
18. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines.
Walker F; Zhang HH; Odorizzi A; Burgess AW
PLoS One; 2011; 6(7):e22733. PubMed ID: 21829496
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP
Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
